Navigation Links
OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
Date:10/11/2007

RICHMOND, Texas, Oct. 11 /PRNewswire/ -- (SEND2PRESS NEWSWIRE) -- OCuSOFT Inc., producer of the popular ocular-lid hygiene products, OCuSOFT(R) Lid Scrub(TM) and OCuSOFT(R) Lid Scrub(TM) PLUS, is responding to a recent advertisement released by Advanced Vision Research (AVR) that was found to be misleading.

*(LOGO 72dpi: Send2Press.com/mediaboom/07-0803-Occusoft_72dpi.jpg)

The study, a bacteria time-kill analysis, compared OCuSOFT's Lid Scrub(TM) PLUS Eyelid Cleanser to AVR's SteriLid(R). However, according to OCuSOFT's Executive Vice President, Patrick Witham, "comparing the bacteria kill rate for these two products based on 30-second time point is like comparing apples to oranges." In addition, no evidence was found in AVR's analysis that results were based on independent-lab setting tests.

While both products are eyelid cleansers, they differ in their application and the time in which each product achieves maximum effectiveness. OCuSOFT(R) Lid Scrub(TM) PLUS can be used as a leave-on therapy, while SteriLid(R), according to manufacturer instructions, should be left in place for 60-seconds to achieve maximum effectiveness.

The AVR advertisement compared OCuSOFT(R) Lid Scrub(TM) PLUS and SteriLid(R) at the 30-second time point.

"Unlike SteriLid(R), OCuSOFT(R) Lid Scrub(TM) PLUS was never intended to achieve maximum effectiveness at 30-seconds," Witham said.

OCuSOFT conducted their own study, performed by an independent laboratory, Antimicrobial Test Laboratories, LLC, which tested OCuSOFT(R) Lid Scrub(TM) PLUS after 60-seconds, 60-minutes and 120-minutes. Bacteria reductions were greatest at contact times corresponding with instructions for "leave-on" application. At 120-minutes, at least a 99.9% bacteria reduction was realized on all bacteria, and for some, as much as 99.99%.

For comprehensive, independent laboratory study results, visit: http://www.ocusoft.com/studies/studyresults.html.

"For a true comparison," Witham explained, "AVR should have compared OCuSOFT(R) Lid Scrub(TM) PLUS at the 120-minute time point to SteriLid(R) at the 60-second time point." They would have found that OCuSOFT(R) is more effective.

OCuSOFT(R) Lid Scrub(TM) PLUS was developed with an understanding that most patients, and even health care providers, will not spend 60-seconds applying a solution and rinsing it off.

Emily Sickbert-Bennet, a public health epidemiologist with the University of North Carolina Health Care System and the UNC School of Public Health conducted a study that illustrates that, on average, health care providers spend less than 10-seconds scrubbing their hands.

"This is important information that should not be dismissed. The parallels that can be drawn between these hygiene regimens speak volumes about the likelihood of a patient realistically complying with a 60-second eyelid scrubbing regimen," Witham said. "We developed this practically non- irritating formula in an effort to increase patient compliance. What good is served by recommending a regimen that patients will not adhere to?"

OCuSOFT, Inc. specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They address clinical needs through well-researched and technological solutions, while improving patient compliance.

For a free sample of OCuSOFT(R) Lid Scrub(TM) PLUS, click: http://www.ocusoft.com/sample1.html. For more information about the company and their products, visit: http://www.ocusoft.com.

All trademarks acknowledged.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE OCuSOFT Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study Refutes Theory on HIVs Effect on White Blood Cells
2. Comparison between warfarin and aspirin
3. Clinical Comparisons Between ADHD Drugs Are Less
4. Differences in brain pattern among liars and cheats in comparison to honest people
5. Rural Canadians travel far for specialists: study
6. A new study surpasses Gene Therapy Hurdle
7. Tomato Sauce reduces Cancer Risk- Study
8. A question on study of Adult Stem Cell
9. Study on obesity and heart failure
10. National Lung Study in the process
11. Marijuana gateway theory strengthened by study of twins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters of Science ... evaluation leaders with decades of experience who remain current practitioners in the field. ... system, there is a renewed demand for versatile, data-driven leadership.The American University’s MS ...
(Date:1/23/2017)... ... January 23, 2017 , ... Moisture measurement is a ... method is paramount to success. Selecting an inappropriate measurement method can cause costly ... use the same equipment. Rare or expensive substances are wasted and production may ...
(Date:1/23/2017)... ... January 23, 2017 , ... Gynecology Associates of ... gynecological services for women of all ages. The staff of Gynecology ... of reproductive services from routine health screenings to diagnosing and treating female concerns ...
(Date:1/23/2017)... ... ... “Some Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the ... of published author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He ... nineteen, a pastor for over fifteen years. He is a graduate of N.C. College ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Jan 23, 2017 Research and Markets has announced ... Trends - Product - Forecast to 2025" report to their offering. ... Report Highlights: ... market trends to identify the investment opportunities Market forecasts ... Key market trends across the business segments, Regions and Countries ...
(Date:1/23/2017)... Jan. 23, 2017  Using Astute Medical,s ... risk for acute kidney injury (AKI) after open-heart ... care guidelines significantly improved outcomes by ... more than 33 percent, according to a ... Intensive Care Medicine. Experience ...
(Date:1/23/2017)... January 23, 2017 Ahead of today,s trading ... how they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... were relative laggards on Friday, January 20 th , 2017, down ... research reports on these stocks now at: ...
Breaking Medicine Technology: